Ç 29 È Ïñ a w ë Ñ } ñÀ ® ® « ûplaza.umin.ac.jp/yuketsuk/resources/平成29... ·...
42
LJȀ29LjǏñšŷƋ˫ЉϑͽϱÀή ή « ϻ ɀ ɊуLJȀ29Lj10ɓ11ɀ( ʗ)12ɀеəж ŭ ȅуsŷÿ ǜ˦ɰ ŷ ÿ ŷ Ƌ
Transcript of Ç 29 È Ïñ a w ë Ñ } ñÀ ® ® « ûplaza.umin.ac.jp/yuketsuk/resources/平成29... ·...
29
29 10 11 ( )12
1
49
92
2
3
29
28
4
5
28
6
28
98 8,500 13
1,120 116 9,620
226 8,620 109 9,000
116 9,620
30
15
12
7
2025
15
2025
26
2,500
28
5,000
12
8
29
27
30
10
31
29
9
COI COI
COI
30
50
2025
2025
45 360
720
10
31
36
30
31
11 12
11 12
12
11
20
11
14
31
14
12
10
20 30
2020
28 191
483
2
68 21
17 28
13
g/dL 1A 1A
2C 2D
5 / L 2D
2 /mL 2D
PT 2.0 30 APTT
2 25 100mg/dL
150
2B
10 15mL/kg
2.5
14
3.0g/dL 2.5g/dL
1B 2D 1B
2B 2D
2D
1B
200 400mL
1A
2C
15
MTP Massive Transfusion Protocol
16
AABB
AABB Trauma hemostasis&Oxygenation Research:
THOR AABB/THOR Joint Working Group
Hemorrhagic Shock Resuscitation Workshop
preventable death
COI
30
17
100
FFP 1.5
FFP
civilian
FFP FFP
FFP
16 FFP
FFP
30
1:1:1
FFP,
FFP
FFP
FFP
FFP FFP
FFP FFP
FFP
survivorship bias
survivorship bias
survivorship bias Plasma: RCC
FFP
cutoff 1 1 30
18
survivorship bias 30
905 25
24
plasma:RBC
platelets:RBC 6
24 FFP 24
FFP
FFP
survivorship bias 24
disadvantage
FFP Thawed plasma
plasma
AB
AB AB low titer B A
TRALI
FFP
vWF von Willebrand factor vWF N
FFP
FFP
19
PROPPR study Plasma:
FFP container
container
FFP
FFP
10
24 30 all-cause mortality
1:1:1
24
thawed plasma
AB AB
A Universal donor
Massive Transfusion Protocols
30
PROPPR study
container
container
15
Massive Transfusion Protocols
15 10
20
AABB
FFP
Massive Transfusion Protocols
post-hock 24
survivorship bias 24
FFP
plasma
Massive
Transfusion Protocols
FFP
Blood Bank
Blood Bank
1-
thawed
plasma
AABB
21
AABBstandards
AABB low titer group O AABB standards
low titer group O A
B 256 O
FFP
400cc
Freeze-dried plasma
Refrigerated Platelets
cold platelets FDA
cold platelets
cold platelets 14
cold platelets
Massive Transfusion Protocols
22
Massive Transfusion Protocols
VII
primary endpoint
Rahe-Meyer Hannover
150
2017
200
feasibility study
ROTEM PCC
prothrombin complex concentrate
RCT
23
plasma
Grade 1B 1C
30
ROTEM
TEG
FFP
AABB
40
FFP
POC device
1 1 1
DIC
PAI-1
MTP MTP MTP
24
MTP
prehospital
Freeze-dried
plasma MTP
MTP
FFP
FFP
25
Massive Transfusion Protocols Damage
Control Resuscitation
Damage Control
Resuscitation Massive Transfusion Protocols
cold platelets
26
cold platelets
FDA
AABB
MTP
FFP
MTP
1B
150 200
1C
Transfusion
125 123 MTP
27
93
ER 4 1
2 25 28
10
108
8,345
O
11.5 1,225
O
MTP
MTP
MTP 10
O MTP
10 n=10
MTP
FFP
FFP MTP
2016 1 106 23
10 n=10
28
MTP 15
FFP 30
15 50 MTP
MTP
MTP
MTP
MTP
FFP
MTP TACO
MTP
MTP O 10
FFP FFP
FFP
FFP
MTP 72
29
AMED
MTP
O
MTP
FFP
30
MTP
31
19
5.5 12.7
21
12
ABO
20
32
O
A4
33
2006
2012 58
2023
Advanced OSCE
Post-Clinical Clerkship OSCE
34
53 73
37 44
39 38
Cell Processing Center
40
90
78
35
93 100
199 164 25
145
616 313 15
240
52
14 31 4
731 HLA 50
FFP
20
28 11 6,000
20
21 13.2 25
9.8
FFP PC 20
FFP
79
36
23
HLA
A&T
78
72
92
12
10
37
IC
IC
38
31 64
31
2019 31 11 14
18
39
10 19
10
40
41
![g ? > Z31 9 £ ¦ª ? #®WFC ¬cvsR Z} q6 r ft { K y~WFC%a ¢ {oWFC … · 2018. 2. 26. · 8N%* £®mi 8N¡ § £®kni ¤©« £®lj¯mj 8==RIhta]_dP zFacebookiwa2I C 0/z ...](https://static.fdocuments.pl/doc/165x107/5fda0fc735ce510117234b81/g-z31-9-wfc-cvsr-z-q6-r-ft-k-ywfca-owfc-2018.jpg)
![¥# @ J ! 2 1 L!®Lì E K 2 9 2 2 2 6 1 1 1 2 5 2 1 L ¹e:j|iÿLì H s ...www.北面.tw/pdf/2019TNF100_10k_qroup.pdf3 1 2 : ! U O G 2 1 1 !&³fC]2av]y2¹1Ø\¥# @ J ! 2 1 L!®Lì Yª%VM](https://static.fdocuments.pl/doc/165x107/60822391c9498837d130c86e/-j-2-1-ll-e-k-2-9-2-2-2-6-1-1-1-2-5-2-1-l-ejil-h-s-wwwoeetwpdf2019tnf10010kqrouppdf.jpg)